Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis
暂无分享,去创建一个
G. Lip | H. Heidbuchel | R. de Caterina | A. Goette | J. Le Heuzey | M. Ezekowitz | S. Themistoclakis | J. Merino | B. Merkely | M. Melino | James Jin | S. M. Winters | J. D. de Groot | A. Cohen | S. Winters
[1] G. Lip,et al. Abstract 14839: Transesophageal Echocardiography-Guided Strategy vs Conventional Anticoagulation for Cardioversion of Atrial Fibrillation: An Analysis of Thromboembolic and Bleeding Events From the ENSURE-AF Study , 2018 .
[2] B. Gersh,et al. Real-Time Pathophysiologic Correlates of Left Atrial Appendage Thrombus in Patients Who Underwent Transesophageal-Guided Electrical Cardioversion for Atrial Fibrillation. , 2018, The American journal of cardiology.
[3] A. Goette,et al. Atrial thrombogenesis in atrial fibrillation , 2018, Herzschrittmachertherapie + Elektrophysiologie.
[4] S. Iliceto,et al. NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world. , 2017, International journal of cardiology.
[5] S. Willems,et al. Risk stratification of patients with left atrial appendage thrombus prior to catheter ablation of atrial fibrillation: An approach towards an individualized use of transesophageal echocardiography , 2017, Journal of cardiovascular electrophysiology.
[6] X. Fang,et al. Association of CHADS2 and CHA2DS2-VASc Scores with Left Atrial Thrombus with Nonvalvular Atrial Fibrillation: A Single Center Based Retrospective Study in a Cohort of 2695 Chinese Subjects , 2017, BioMed research international.
[7] A. Aidietis,et al. Findings of transoesophageal echocardiogram in appropriately anticoagulated patients with persistent atrial fibrillation prior to planned cardioversion , 2017, BMC Cardiovascular Disorders.
[8] G. Lip,et al. Stroke prevention in atrial fibrillation: Past, present and future. , 2017, Thrombosis and haemostasis.
[9] G. Lip,et al. Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial , 2016, The Lancet.
[10] G. Lip,et al. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[11] P. Kirchhof,et al. Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE trial. , 2016, American heart journal.
[12] U. Tebbe,et al. Left atrial thrombi and spontaneous echo contrast in patients with atrial fibrillation , 2016, Herz.
[13] M. N. D. Minno,et al. Prevalence of left atrial thrombus in patients with non-valvular atrial fibrillation , 2015, Thrombosis and Haemostasis.
[14] G. Lip,et al. A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study. , 2015, American heart journal.
[15] A. Camm,et al. Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation. , 2014, European heart journal.
[16] B. Lindsay,et al. Efficacy of the CHADS₂ scoring system to assess left atrial thrombogenic milieu risk before cardioversion of non-valvular atrial fibrillation. , 2013, The American journal of cardiology.
[17] J. Halperin,et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. , 2001, The New England journal of medicine.
[18] G. Lip,et al. Cardioversion of atrial fibrillation. , 1995, Postgraduate medical journal.
[19] H. Krumholz,et al. Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. , 1993, The New England journal of medicine.